1189 related articles for article (PubMed ID: 29498023)
1. Treatment of Heart Failure with Preserved Ejection Fraction.
Ilieșiu AM; Hodorogea AS
Adv Exp Med Biol; 2018; 1067():67-87. PubMed ID: 29498023
[TBL] [Abstract][Full Text] [Related]
2. Heart failure with preserved ejection fraction: current management and future strategies : Expert opinion on the behalf of the Nucleus of the "Heart Failure Working Group" of the German Society of Cardiology (DKG).
Tschöpe C; Birner C; Böhm M; Bruder O; Frantz S; Luchner A; Maier L; Störk S; Kherad B; Laufs U
Clin Res Cardiol; 2018 Jan; 107(1):1-19. PubMed ID: 29018938
[TBL] [Abstract][Full Text] [Related]
3. Heart failure with mid-range ejection fraction in CHARM: characteristics, outcomes and effect of candesartan across the entire ejection fraction spectrum.
Lund LH; Claggett B; Liu J; Lam CS; Jhund PS; Rosano GM; Swedberg K; Yusuf S; Granger CB; Pfeffer MA; McMurray JJV; Solomon SD
Eur J Heart Fail; 2018 Aug; 20(8):1230-1239. PubMed ID: 29431256
[TBL] [Abstract][Full Text] [Related]
4. A comprehensive population-based characterization of heart failure with mid-range ejection fraction.
Koh AS; Tay WT; Teng THK; Vedin O; Benson L; Dahlstrom U; Savarese G; Lam CSP; Lund LH
Eur J Heart Fail; 2017 Dec; 19(12):1624-1634. PubMed ID: 28948683
[TBL] [Abstract][Full Text] [Related]
5. Different relationships between pulse pressure and mortality in heart failure with reduced, mid-range and preserved ejection fraction.
Teng TK; Tay WT; Dahlstrom U; Benson L; Lam CSP; Lund LH
Int J Cardiol; 2018 Mar; 254():203-209. PubMed ID: 29407092
[TBL] [Abstract][Full Text] [Related]
6. Heart failure with preserved ejection fraction has a better long-term prognosis than heart failure with reduced ejection fraction in old patients in a 5-year follow-up retrospective study.
Kontogeorgos S; Thunström E; Johansson MC; Fu M
Int J Cardiol; 2017 Apr; 232():86-92. PubMed ID: 28100428
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of de novo and acute decompensated heart failure patients according to ejection fraction.
Choi KH; Lee GY; Choi JO; Jeon ES; Lee HY; Cho HJ; Lee SE; Kim MS; Kim JJ; Hwang KK; Chae SC; Baek SH; Kang SM; Choi DJ; Yoo BS; Kim KH; Park HY; Cho MC; Oh BH
Heart; 2018 Mar; 104(6):525-532. PubMed ID: 28982721
[TBL] [Abstract][Full Text] [Related]
8. Drugs That Ameliorate Epicardial Adipose Tissue Inflammation May Have Discordant Effects in Heart Failure With a Preserved Ejection Fraction as Compared With a Reduced Ejection Fraction.
Packer M
J Card Fail; 2019 Dec; 25(12):986-1003. PubMed ID: 31541742
[TBL] [Abstract][Full Text] [Related]
9. Heart Failure With Mid-Range (Borderline) Ejection Fraction: Clinical Implications and Future Directions.
Hsu JJ; Ziaeian B; Fonarow GC
JACC Heart Fail; 2017 Nov; 5(11):763-771. PubMed ID: 29032140
[TBL] [Abstract][Full Text] [Related]
10. Thromboembolisms in atrial fibrillation and heart failure patients with a preserved ejection fraction (HFpEF) compared to those with a reduced ejection fraction (HFrEF).
Sobue Y; Watanabe E; Lip GYH; Koshikawa M; Ichikawa T; Kawai M; Harada M; Inamasu J; Ozaki Y
Heart Vessels; 2018 Apr; 33(4):403-412. PubMed ID: 29067492
[TBL] [Abstract][Full Text] [Related]
11. Acute heart failure with mid-range left ventricular ejection fraction: clinical profile, in-hospital management, and short-term outcome.
Farmakis D; Simitsis P; Bistola V; Triposkiadis F; Ikonomidis I; Katsanos S; Bakosis G; Hatziagelaki E; Lekakis J; Mebazaa A; Parissis J
Clin Res Cardiol; 2017 May; 106(5):359-368. PubMed ID: 27999929
[TBL] [Abstract][Full Text] [Related]
12. Medical Therapies for Heart Failure With Preserved Ejection Fraction.
Kjeldsen SE; von Lueder TG; Smiseth OA; Wachtell K; Mistry N; Westheim AS; Hopper I; Julius S; Pitt B; Reid CM; Devereux RB; Zannad F
Hypertension; 2020 Jan; 75(1):23-32. PubMed ID: 31786973
[TBL] [Abstract][Full Text] [Related]
13. Advance in the pharmacological and comorbidities management of heart failure with preserved ejection fraction: evidence from clinical trials.
Meifang W; Ying W; Wen C; Kaizu X; Meiyan S; Liming L
Heart Fail Rev; 2024 Mar; 29(2):305-320. PubMed ID: 37561223
[TBL] [Abstract][Full Text] [Related]
14. Effects of vasodilation in heart failure with preserved or reduced ejection fraction implications of distinct pathophysiologies on response to therapy.
Schwartzenberg S; Redfield MM; From AM; Sorajja P; Nishimura RA; Borlaug BA
J Am Coll Cardiol; 2012 Jan; 59(5):442-51. PubMed ID: 22281246
[TBL] [Abstract][Full Text] [Related]
15. Sex-related differences in chronic heart failure: a community-based study.
Russo G; Rea F; Barbati G; Cherubini A; Stellato K; Scagnetto A; Iorio A; Corrao G; Di Lenarda A
J Cardiovasc Med (Hagerstown); 2021 Jan; 22(1):36-44. PubMed ID: 32740424
[TBL] [Abstract][Full Text] [Related]
16. Pathophysiology-based novel pharmacotherapy for heart failure with preserved ejection fraction.
Konstantinou DM; Chatzizisis YS; Giannoglou GD
Pharmacol Ther; 2013 Nov; 140(2):156-66. PubMed ID: 23792088
[TBL] [Abstract][Full Text] [Related]
17. Worsening renal function and outcome in heart failure patients with reduced and preserved ejection fraction and the impact of angiotensin receptor blocker treatment: data from the CHARM-study programme.
Damman K; Solomon SD; Pfeffer MA; Swedberg K; Yusuf S; Young JB; Rouleau JL; Granger CB; McMurray JJ
Eur J Heart Fail; 2016 Dec; 18(12):1508-1517. PubMed ID: 27427441
[TBL] [Abstract][Full Text] [Related]
18. Heart Failure With Mid-range Ejection Fraction.
Srivastava PK; Hsu JJ; Ziaeian B; Fonarow GC
Curr Heart Fail Rep; 2020 Feb; 17(1):1-8. PubMed ID: 31925667
[TBL] [Abstract][Full Text] [Related]
19. Heart failure with preserved ejection fraction: pathophysiology and emerging therapies.
From AM; Borlaug BA
Cardiovasc Ther; 2011 Aug; 29(4):e6-21. PubMed ID: 20370792
[TBL] [Abstract][Full Text] [Related]
20. Heart failure with preserved ejection fraction: a clinical dilemma.
Komajda M; Lam CS
Eur Heart J; 2014 Apr; 35(16):1022-32. PubMed ID: 24618346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
